APA (7th ed.) Citation

RM, F., BA, F., C, H., & LA, P. (2022). Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments. Breast cancer research and treatment, 196(1), 17. https://doi.org/10.1007/s10549-022-06715-z

Chicago Style (17th ed.) Citation

RM, Ferraiuolo, Fifield BA, Hamm C, and Porter LA. "Stabilization of C-Myc by the Atypical Cell Cycle Regulator, Spy1, Decreases Efficacy of Breast Cancer Treatments." Breast Cancer Research and Treatment 196, no. 1 (2022): 17. https://doi.org/10.1007/s10549-022-06715-z.

MLA (9th ed.) Citation

RM, Ferraiuolo, et al. "Stabilization of C-Myc by the Atypical Cell Cycle Regulator, Spy1, Decreases Efficacy of Breast Cancer Treatments." Breast Cancer Research and Treatment, vol. 196, no. 1, 2022, p. 17, https://doi.org/10.1007/s10549-022-06715-z.